Albert Einstein College of Medicine Researchers Receive $5 Million NIH Grant to Study HIV and HPV Cancers in Africa
November 13, 2020—(BRONX, NY)—A team of scientists fromAlbert Einstein College of Medicine has received a five-year, $4.9 million grant from the National Institutes of Health (NIH) to establish a research center to investigate HIV- and human papillomavirus (HPV)-related cancers in Africa. (Source: Einstein News)
Source: Einstein News - November 13, 2020 Category: Universities & Medical Training Source Type: news
Albert Einstein College of Medicine researchers receive $5 million NIH grant to study HIV and HPV cancers in Africa
(Albert Einstein College of Medicine) A team of scientists from Albert Einstein College of Medicine has received a five-year, $4.9 million grant from the National Institutes of Health (NIH) to establish a research center to investigate HIV- and human papillomavirus (HPV)-related cancers in Africa. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2020 Category: Cancer & Oncology Source Type: news
HPV Vaccine Generally Well Tolerated in Males
WEDNESDAY, Nov. 4, 2020 -- Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology.
Giulia Bonaldo,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 4, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccination Remains Below Healthy People Goals HPV Vaccination Remains Below Healthy People Goals
Rates of human papillomavirus vaccination increased for both boys and girls in the United States over the past decade but remain below target levels and vary widely among states.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 14, 2020 Category: Infectious Diseases Tags: Pediatrics News Source Type: news
Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 8, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Impact of HPV vaccination mandates on social inequalities
(University of California - Riverside) A postdoctoral researcher at the University of California, Riverside, has discovered Human papillomavirus, or HPV, vaccination mandates fall short of ensuring both higher levels of uptake and equal uptake of the vaccine across socioeconomic and racial-ethnic groups. The findings could help facilitate equal access to and compliance with uptake of COVID-19 vaccines, once they are available. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 5, 2020 Category: Infectious Diseases Source Type: news
HPV Vaccination Tied to Decrease in Invasive Cervical Cancer Risk
THURSDAY, Oct. 1, 2020 -- Quadrivalent human papillomavirus (HPV) vaccination of girls and women aged 10 to 30 years is associated with a reduced risk for invasive cervical cancer, according to a study published in the Oct. 1 issue of the New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 1, 2020 Category: Pharmaceuticals Source Type: news
HPV Vaccine Proves Its Mettle Against Cervical Cancer
WEDNESDAY, Sept. 30, 2020 -- Girls who are vaccinated against human papillomavirus (HPV) may drastically cut their chances of developing cervical cancer by age 30, a huge, new study finds.
Researchers found that of more than 1.6 million young... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 30, 2020 Category: General Medicine Source Type: news
A Cross-Sectional Survey to Evaluate Potential for Partnering With School Nurses to Promote Human Papillomavirus Vaccination
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - September 24, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news
Is HPV Human Papilloma Virus an STD
Is HPV (Human Papilloma Virus) an STD? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 23, 2020 Category: General Medicine Source Type: news
Cancers Associated with Human Papillomavirus in American Indian and Alaska Native Populations - United States, 2013-2017
This report describes incidence of human papillomavirus--associated cancers in American Indian and Alaska Native populations in the United States during 2013-2017. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 17, 2020 Category: American Health Tags: American Indian - Alaska Native Health Cancer HPV Infection (Human Papillomavirus) MMWR Morbidity & Mortality Weekly Report Source Type: news
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Investor Update - September 16, 2020 Category: Pharmaceuticals Source Type: news
Roche receives FDA approval for expanded use of the CINtec PLUS Cytology test to aid clinicians in preventing cervical cancer
Basel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec®PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results are positive for high-risk types of human papillomavirus (HPV). Additional information from this test supports clinical decisions about which women will benefit most from immediate follow-up. Laboratories can now use CINtecPLUS Cytology to triage positive results from the cobas ® HPV Test run on the fully integrated, automated and high-throughput co...
Source: Roche Media News - September 16, 2020 Category: Pharmaceuticals Source Type: news
